Mycobacterial infections in renal allograft recipients.
Delaney
V
V
Department of Surgery, State University of New York Health Science Center, Brooklyn.
Sumrani
N
N
Hong
J H
JH
Sommer
B
B
D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006679:HIV Seropositivity; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D009518:New York; D011183:Postoperative Complications / Q000453:epidemiology* / Q000382:microbiology; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin